Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

NCT00253630

Conditions
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Completed

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00445952

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • CHU de Grenoble - Hopital de la Tronche Grenoble, France
  • German Hodgkin's Lymphoma Study Group Cologne, Germany
  • Ospedale San Martino Genoa, Italy
View Trial Details
Completed

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

NCT01460134

Conditions
Adenocarcinoma, Adnexal Diseases, Any T-cell Malignancy, +70 more
Locations
  • Mayo Clinic Arizona - Cancer Clinical Research Unit Scottsdale, Arizona, United States
  • Stanford Cancer Center - Stanford University Stanford, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine New York, United States
View Trial Details
Completed

SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients

NCT01472887

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Investigational Site Number 840001 Denver, Colorado, United States
  • Investigational Site Number 840003 Augusta, Georgia, United States
  • Investigational Site Number 840005 Boise, Idaho, United States
  • Investigational Site Number 056002 Ghent, Belgium
View all 28 locations
View Trial Details
Completed

Carfilzomib Plus Belinostat in Relapsed/Refractory NHL

NCT02142530

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Diffuse Large B-cell Lymphoma, +27 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a

NCT01724021

Conditions
Diffuse Large B-Cell Lymphoma, Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Buenos Aires, Argentina
  • Corrientes, Argentina
  • Santa Fe, Argentina
  • Canberra, Australian Capital Territory, Australia
View all 246 locations
View Trial Details

Related conditions